SS-31 cost oof
Question about the rationale for low-dose SS-31
I've been looking into SS-31 (elamipretide) for longevity and noticed that quite a few people here report using ~4 or 5 mg/day or even lower for 2–4 weeks.
I'm curious about the reasoning behind this, because when I look at the human evidence, I can't really find a clear basis for that particular dosing strategy.
As far as I understand:
- 40 mg/day is by far the best-studied long-term subcutaneous dose in humans.
- Lower doses such as 4–20 mg have been investigated pharmacokinetically, but I haven't found good human data showing that 4 mg/day improves mitochondrial function or produces a meaningful longevity-related outcome.
- There are studies showing that SS-31 can affect mitochondrial bioenergetics in humans, but these don't seem to establish a clear dose-response relationship for low-dose subcutaneous use.
- I also haven't found evidence that 2–4 weeks of low-dose SS-31 has a measurable effect on "mitochondrial health" or longevity in otherwise healthy people.
So I'm wondering:
Why specifically 4 or 5 mg/day (or less)?
Is this based on:
- a particular study or dose-response analysis,
- pharmacokinetic/pharmacodynamic reasoning,
- animal data,
- the idea that mitochondrial effects are already saturated at very low doses,
- personal biomarker results,
- or mainly anecdotal experience?
I'm not arguing that low-dose SS-31 doesn't work — I'm genuinely trying to understand the rationale. If there's evidence I've missed, I'd really appreciate links to the relevant studies.
Also, if you're using 4 mg or less, what outcome are you actually trying to improve or measure, and why did you choose that dose and treatment duration?
Is this a cost speculation type situation? Cause it's SOOOO expensive. 40mg a day would be a couple of grand a month.